Teladoc Health, Inc. (TDOC)
| Market Cap | 1.16B -9.0% |
| Revenue (ttm) | 2.49B -2.1% |
| Net Income | -177.40M |
| EPS | -0.99 |
| Shares Out | 181.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,470,777 |
| Open | 6.50 |
| Previous Close | 6.49 |
| Day's Range | 6.35 - 6.54 |
| 52-Week Range | 4.40 - 9.89 |
| Beta | 2.13 |
| Analysts | Hold |
| Price Target | 7.74 (+21.13%) |
| Earnings Date | Jul 29, 2026 |
About TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through we... [Read more]
Financial Performance
In 2025, Teladoc Health's revenue was $2.53 billion, a decrease of -1.54% compared to the previous year's $2.57 billion. Losses were -$200.32 million, -79.99% less than in 2024.
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for TDOC stock is "Hold." The 12-month stock price target is $7.74, which is an increase of 21.13% from the latest price.
News
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby yo...
Teladoc put volume heavy and directionally bearish
Bearish flow noted in Teladoc (TDOC) with 1,603 puts trading, or 3x expected. Most active are Aug-26 8 puts and Aug-26 11 calls, with total volume in those strikes near…
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquill...
Teladoc price target lowered to $7.50 from $11 at Citi
Citi lowered the firm’s price target on Teladoc (TDOC) to $7.50 from $11 and keeps a Neutral rating on the shares.
Teladoc price target lowered to $8 from $9 at Jefferies
Jefferies analyst Brian Tanquilut lowered the firm’s price target on Teladoc (TDOC) to $8 from $9 and keeps a Hold rating on the shares. Q2 “illustrates the thesis that keeps…
Teladoc price target lowered to $7.50 from $10 at Evercore ISI
Evercore ISI lowered the firm’s price target on Teladoc (TDOC) to $7.50 from $10 and keeps an In Line rating on the shares.
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt
Teladoc shares fell more than 20% before the bell on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental health services uni...
Teladoc price target lowered to $10 from $11 at Canaccord
Canaccord lowered the firm’s price target on Teladoc (TDOC) to $10 from $11 and keeps a Buy rating on the shares. The firm said Teladoc had a revenue miss and…
Teladoc Health Earnings Call Transcript: Q2 2026
Q2 results met guidance with Integrated Care outperforming and BetterHelp pressured by a rapid shift from cash pay to insurance, outpacing provider capacity. 2026 revenue guidance was lowered due to cash pay declines, but insurance revenue and margin guidance were reaffirmed. Teladoc One was launched as a new care model.
Teladoc Health Slides: Q2 2026
Teladoc Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Teladoc Health Earnings release: Q2 2026
Teladoc Health released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Teladoc Health Quarterly report: Q2 2026
Teladoc Health has published its Q2 2026 quarterly earnings report on July 29, 2026.
Teladoc reports Q2 EPS (21c), consensus (22c)
Reports Q2 revenue $606.9M, consensus $616.33M. “We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc (TDOC) Health. Our second-quarter resu...
Teladoc Health Reports Second Quarter 2026 Results
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Qua...
Teladoc Health Canada Achieves Accreditation Canada Primer Award, Advancing Quality Standards for Virtual and Hybrid Care in Canada
TORONTO--(BUSINESS WIRE)--Teladoc Health Canada (Teladoc) has achieved the Accreditation Canada Primer Award, providing independent validation of its commitment to delivering safe, high-quality, and p...
Teladoc down 3% as OpenAI announces launch of Health in ChatGPT
Shares of Teladoc (TDOC) are down 29c, or 3%, to $8.64 in afternoon trading.
Teladoc price target raised to $11 from $7 at Citi
Citi raised the firm’s price target on Teladoc (TDOC) to $11 from $7 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the health…
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care
Teladoc price target raised to $11 from $10 at Canaccord
Canaccord analyst Richard Close raised the firm’s price target on Teladoc (TDOC) to $11 from $10 and keeps a Buy rating on the shares. The firm updated its model heading…
Teladoc Health to Announce Second Quarter 2026 Financial Results
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026,...
Teladoc price target raised to $10.50 from $9 at BofA
BofA raised the firm’s price target on Teladoc (TDOC) to $10.50 from $9 and keeps a Buy rating on the shares. June Sensor Tower data suggests BetterHelp user engagement may…
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ...
Teladoc Health Expands Access to Care Through Walmart's Better Care Services
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced its services are now available through Walmart's Better Care Services platfor...
Teladoc Health Transcript: AGM 2026
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by majority vote. Stockholders participated virtually, and final results will be disclosed in a Form 8-K.